Premium Serums And Vaccines Private Limited, a active private limited company, was established on 29 January 2009 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110MH2009PTC189968. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.
It upholds a compliant status. Employing 82 professional, Its leadership includes Shyam Bhalchandra Dhawan (Director), Girish Nathuram Kolwankar (Director). It holds ₹75.10 Cr open charges and no settled loans. Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at 406, B Wing,Highway Rose Co-Op Hsg Society 92, Dixit Road Extn.,Vile Parle (East), Mumbai, Maharashtra, 400057.
U24110MH2009PTC189968
189968
29 January 2009
₹2.00 Cr
₹2.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Premium Serums And Vaccines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Bhalchandra Dhawan | Director | 29 Jan 2009 | Current |
| Girish Nathuram Kolwankar | Director | 29 Jan 2009 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Premium Serums And Vaccines Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.43% increase. The company also saw a substantial improvement in profitability, with a 27.35% increase in profit. The company's net worth Soared by an impressive increase of 386.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Premium Serums And Vaccines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹751,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2025 | Others | ₹3.00 Cr | Open |
| 25 Mar 2025 | Others | ₹10.67 Cr | Open |
| 16 Dec 2023 | Others | ₹2.60 M | Open |
| 13 Dec 2023 | Others | ₹4.60 Cr | Open |
| 09 May 2023 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Premium Serums And Vaccines has a workforce of 82 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Premium Serums And Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premium Serums And Vaccines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Premium Serums And Vaccines Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was documented.
Premium Serums And Vaccines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101081774 was registered on 26 Mar 2025. was documented.
The activity A charge with Others amounted to Rs. 10.67 Cr with Charge ID 101080971 was registered on 25 Mar 2025. was completed.
Progress on A charge with Others amounted to Rs. 0.26 Cr with Charge ID 100840859 was registered on 16 Dec 2023. was documented.
A charge with Others amounted to Rs. 4.60 Cr with Charge ID 100840858 was registered on 13 Dec 2023. was recorded as a recent event.
The CIN of Premium Serums And Vaccines Private Limited is U24110MH2009PTC189968.
Premium Serums And Vaccines Private Limited is headquartered at 406, B Wing,Highway Rose Co-Op Hsg Society 92, Dixit Road Extn.,Vile Parle (East), Mumbai, Maharashtra, 400057.
Premium Serums And Vaccines Private Limited was incorporated on 29 January 2009.
The current directors of Premium Serums And Vaccines Private Limited are
The primary industry of Premium Serums And Vaccines Private Limited is Manufacturing.
Premium Serums And Vaccines Private Limited is unlisted.
The authorized capital of Premium Serums And Vaccines Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.
The compliance status of Premium Serums And Vaccines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX